FindTrial
Sign In

Incidence of intrauterine adhesion after use of Floseal to control placental bed bleeding

Incidence of intrauterine adhesion after use of Floseal to control placental bed bleeding

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014589
Enrollment
Unknown
Registered
2018-01-23
Start date
2018-01-17
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrauterine adhesion placental bed bleeding

Interventions

Case series:All women who had Floseal applied to intrauterine cavity during Caesarean section will be invited to participate in the study by our research assistant. For those who agree to join the stu

Sponsors

Prince of Wales Hospital, The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All women presenting to our unit with use of FloSeal to control postpartum haemorrhage during Caesarean Section will be invited to join the study.

Exclusion criteria

Exclusion criteria: Women who did not have Floseal applied in intrauterine cavity during Caesarean

Design outcomes

Primary

MeasureTime frame
To determine the incidence of intrauterine adhesion or Asherman’s syndrome after usage of Floseal to control postpartum haemorrhage;—

Countries

China

Contacts

Public ContactDr. CHUNG Pui Wah, Jacqueline

Department of OG, Prince of Wales Hospital

jacquelinechung@cuhk.edu.hk+852 35051537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026